Showing results (21-30 of 56) with videos related to

Sort By:
Pageof 6
Bioorganic & Medicinal Chemistry Letters|April 29, 2014
Bis-aryloxadiazoles as effective activators of the aryl hydrocarbon receptorKaitlin J Basham, Vasudev R Bhonde, Collin Kieffer, et al.
Genes & Cancer|March 15, 2013
Targeting the PyMT Oncogene to Diverse Mammary Cell Populations Enhances Tumor Heterogeneity and Generates Rare Breast Cancer SubtypesBrittni A Smith, Dawne N Shelton, Collin Kieffer, et al.
Current Protocols in Pharmacology|March 5, 2013
Patient-derived models of human breast cancer: protocols for in vitro and in vivo applications in tumor biology and translational medicineYoko S DeRose, Keith M Gligorich, Guoying Wang, et al.
Integrative Biology : Quantitative Biosciences From Nano to Macro|December 22, 2009
Mapping mammary gland architecture using multi-scale in situ analysisRodrigo Fernandez-Gonzalez, Irineu Illa-Bochaca, Bryan E Welm, et al.
Disease Models & Mechanisms|December 3, 2008
Visualizing stromal cell dynamics in different tumor microenvironments by spinning disk confocal microscopyMikala Egeblad, Andrew J Ewald, Hanne A Askautrud, et al.
Breast Cancer Research : BCR|July 25, 2013
Development of a screen to identify selective small molecules active against patient-derived metastatic and chemoresistant breast cancer cellsKeith M Gligorich, Rachel M Vaden, Dawne N Shelton, et al.
STAR Protocols|July 4, 2023
Breast cancer PDxO cultures for drug discovery and functional precision oncologySandra D Scherer, Ling Zhao, Andrew J Butterfield, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|October 1, 2014
Dioxin exposure blocks lactation through a direct effect on mammary epithelial cells mediated by the aryl hydrocarbon receptor repressorKaitlin J Basham, Christopher J Leonard, Collin Kieffer, et al.
NPJ Breast Cancer|September 10, 2022
Immunologically "cold" triple negative breast cancers engraft at a higher rate in patient derived xenograftsVarduhi Petrosyan, Lacey E Dobrolecki, Emily L LaPlante, et al.
Cancer Research|October 16, 2003
Conditional activation of fibroblast growth factor receptor (FGFR) 1, but not FGFR2, in prostate cancer cells leads to increased osteopontin induction, extracellular signal-regulated kinase activation, and in vivo proliferationKevin W Freeman, Rama D Gangula, Bryan E Welm, et al.
Pageof 6